MedTrace Logo

Effectiveness Chronic Kidney Disease & Therapeutic Exercise

NCT03416140 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-03-25

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness and safety of the therapeutic exercise effects in patients with chronic kidney disease. An randomized clinical trial is carried out. A total sample of 70 patients with chronic kidney disease is recruited and divided into a therapeutic exercise group and a control group. The kidney function (creatinine clearance as main outcome) is measured at baseline and 1 month after treatment start.

Conditions

Interventions

OTHER

Therapeutic Exercise

30 minutes per day of therapeutic exercise

Sponsors & Collaborators

  • Universidad de León

    lead OTHER

Principal Investigators

  • Pierre Neyra Bohórquez, MD · Nephrology Unit, Galdakao Hospital, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2021-06-01
Completion
2021-06-15

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03416140 on ClinicalTrials.gov